COVID-19
The global cellular immunotherapy market is expected to decline significantly in 2020 due to the COVID-19 pandemic, but is forecasted to recover and reach $5.05 billion in 2023 at a compound annual growth rate (CAGR) of 22.53%. The market is driven by the development of new cellular immunotherapies
COVID-19
In the face of unprecedented challenges brought about by the COVID-19 pandemic, Focus4Hope, a local charitable organization, has risen to the occasion. Founded in September 2016, Focus4Hope has been working tirelessly to support the elderly, isolated, and vulnerable members of the community. From holding fundraising events for the local homeless
COVID-19
The COVID-19 vaccine rollout in nursing homes has been plagued by slow progress, with health officials and local authorities criticizing CVS and Walgreens, the two companies tasked with administering the vaccine. As of January 14, only a quarter of the 4.7 million doses allocated to the companies had been
COVID-19
As President-elect Joe Biden prepared to take office amidst the ongoing coronavirus pandemic, he reinforced his administration's commitment to vaccination by receiving the second dose of the Pfizer/BioNTech Covid-19 vaccine on Monday. This public display of vaccination serves as a reassurance to the American public, who have
COVID-19
As Ontario continues to struggle with high COVID-19 case counts and the emergence of new, more transmissible variants, concerns are growing over the prioritization of vaccine distribution. Some Toronto hospitals have started vaccinating non-frontline staff, including executives, raising questions about the ethics of immunizing these employees ahead of community health
COVID-19
As the European Union continues to tackle the COVID-19 pandemic, health policy spokesman Peter Liese from the European Parliament stressed the importance of securing sufficient vaccine supplies. The EU has secured 160 million doses of the mRNA-1273 vaccine from Moderna, a US-American manufacturer with production sites on the European continent.
COVID-19
As the United Kingdom announced the approval of the Oxford/AstraZeneca vaccine, a massive drive to vaccinate millions of people got underway. The vaccine, developed by Oxford University and AstraZeneca, was approved by the Medicines and Healthcare Regulatory Agency (MHRA) on December 30, paving the way for a nationwide rollout
COVID-19
Australians can look forward to being fully vaccinated against Covid-19 by the end of October, according to Health Minister Greg Hunt. The country's vaccination rollout is expected to be completed ahead of schedule, with the Pfizer/BioNTech, AstraZeneca/Oxford University, and Novavax vaccines all cleared for use. While
COVID-19
European Union nations have launched a coordinated effort to provide COVID-19 vaccinations to their 450 million citizens, with the most vulnerable populations, including healthcare workers and the elderly, receiving the first jabs. The vaccinations, developed by Germany's BioNTech and American drug maker Pfizer, began arriving in EU countries
COVID-19
The AI in Telecommunication Market report provides a comprehensive overview of the global market, highlighting its vital factors, including market share, profitability, production, sales, manufacturing, advertising, technological advancements, key market players, regional segmentation, and other essential aspects. The report covers the leading players operating in the market, including IBM, Microsoft,
COVID-19
The private-label food and beverage market in the US is expected to grow significantly, with a compound annual growth rate (CAGR) of almost 4% during the forecast period of 2020-2024. This growth is driven by the premiumization of private-label food and beverage products, as well as product line extension by
COVID-19
The Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine, marking a significant milestone in the fight against the pandemic. This decision clears the way for widespread vaccinations to begin, with Phase 1A prioritizing healthcare personnel and long-term care facilities. Pennsylvania'
